$81.5 Million is the total value of Asymmetry Capital Management, L.P.'s 33 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OPTN | New | OPTINOSE INC | $5,682,000 | – | 300,618 | +100.0% | 7.71% | – |
| PRGO | New | PERRIGO CO PLC | $1,580,000 | – | 18,129 | +100.0% | 2.14% | – |
| TEVA | New | TEVA PHARMACEUTICALadr | $1,310,000 | – | 69,124 | +100.0% | 1.78% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $957,000 | – | 10,733 | +100.0% | 1.30% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $858,000 | – | 25,311 | +100.0% | 1.16% | – |
| ARRY | New | ARRAY BIOPHARMA INC | $846,000 | – | 66,095 | +100.0% | 1.15% | – |
| PBYI | New | PUMA BIOTECHNOLOGYINC | $729,000 | – | 7,371 | +100.0% | 0.99% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $539,000 | – | 61,530 | +100.0% | 0.73% | – |
| ECYT | New | ENDOCYTE | $349,000 | – | 81,484 | +100.0% | 0.47% | – |
| KALA | New | KALA PHARMACEUTICALS | $250,000 | – | 13,504 | +100.0% | 0.34% | – |
| PRTO | New | PROTEON THERAPEUTICS INC | $18,000 | – | 9,400 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CENTENE CORP | 21 | Q4 2021 | 10.7% |
| UNITEDHEALTH GROUP INC | 21 | Q4 2021 | 7.2% |
| AMICUS THERAPEUTICS INC | 20 | Q4 2021 | 8.0% |
| PTC THERAPEUTICS INC | 19 | Q3 2021 | 13.8% |
| AERIE PHARMACEUTICALS INC | 16 | Q4 2019 | 9.9% |
| JAZZ PHARMACEUTICALS PLC | 15 | Q2 2021 | 10.2% |
| BIO-RAD LABRATORIES | 13 | Q2 2021 | 6.3% |
| NEVRO CORP | 12 | Q3 2018 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 12 | Q4 2018 | 6.5% |
| NUCANA PLC-ADR | 12 | Q4 2020 | 2.6% |
View Asymmetry Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-01-19 |
| 13F-HR | 2021-11-04 |
| 13F-HR | 2021-07-28 |
| 13F-HR | 2021-05-11 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-06 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-12 |
| 13F-HR | 2019-11-12 |
View Asymmetry Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.